Implied Volatility Surging for Core Laboratories Stock Options
Investors need to pay close attention to CLB stock based on the movements in the options market lately.
CLB - Core Laboratories N.V.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$25.00
DETAILS
HIGH:
$32.00
LOW:
$17.00
MEDIAN:
$26.00
CONSENSUS:
$25.00
UPSIDE:
75.81%
Stock News
Core Laboratories Q1 Earnings Meet Estimates, Decline Y/Y
CLB's Q1 earnings meet estimates but fall Y/Y as a revenue miss and Middle East disruptions weigh on both key segments.
Core Laboratories Inc. (CLB) Q1 2026 Earnings Call Transcript
Core Laboratories Inc. (CLB) Q1 2026 Earnings Call Transcript
CORE LAB REPORTS FIRST QUARTER 2026 RESULTS
REVENUE OF $121.8 MILLION, DOWN 12% SEQUENTIALLY AND FLAT YEAR-OVER-YEAR OPERATING INCOME OF $1.9 MILLION; EX-ITEMS, $6.6 MILLION, DOWN 58% SEQUENTIALLY AND 44% YEAR-OVER-YEAR GAAP LOSS PER SHARE OF $0.02 ; EPS EX-ITEMS OF $0.06, DOWN 72% SEQUENTIALLY AND 58% YEAR-OVER-YEAR FREE CASH FLOW OF $0.5 MILLION NET DEBT INCREASED BY $3.9 MILLION; LEVERAGE RATIO AT 1.20 COMPANY REPURCHASED 51,781 SHARES OF COMMON STOCK, FOR $0.9 MILLION AGGREGATE PURCHASE PRICE COMPANY ANNOUNCES Q2 2026 QUARTERLY DIVIDEND HOUSTON, April 29, 2026 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported first quarter 2026 revenue of $121,800,000. Core's operating income was $1,900,000, with a loss per diluted share of $0.02, all in accordance with U.S. generally accepted accounting principles ("GAAP").
DTI or CLB: Which Is the Better Value Stock Right Now?
Investors interested in Oil and Gas - Field Services stocks are likely familiar with Drilling Tools International Corp. (DTI) and Core Laboratories (CLB). But which of these two stocks presents investors with the better value opportunity right now?
Core Laboratories to Post Q1 Earnings: Key Metrics to Watch
CLB heads into Q1 earnings with lowered guidance, geopolitical disruptions and cost pressures raising concerns over a potential earnings miss.
Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DTI vs. CLB: Which Stock Is the Better Value Option?
Investors interested in stocks from the Oil and Gas - Field Services sector have probably already heard of Drilling Tools International Corp. (DTI) and Core Laboratories (CLB). But which of these two companies is the best option for those looking for undervalued stocks?
DTI vs. CLB: Which Stock Should Value Investors Buy Now?
Investors interested in stocks from the Oil and Gas - Field Services sector have probably already heard of Drilling Tools International Corp. (DTI) and Core Laboratories (CLB). But which of these two stocks presents investors with the better value opportunity right now?
Middle East Conflict Weighs On Core Laboratories' Q1 Outlook
CLB's operations remain disrupted amid geopolitical tensions, forcing a cut in Q1 2026 guidance due to supply chain issues and weaker client activity.
Here's Why Hold Strategy Is Apt for Core Laboratories Stock for Now
CLB is supported by offshore expansion, high-margin services and innovation, but pressured by geopolitical tensions, soft U.S. markets and oil price uncertainty.
CORE LAB ANNOUNCES IMPACT OF THE MIDDLE EAST CONFLICT TO FIRST QUARTER 2026 GUIDANCE
HOUSTON, March 23, 2026 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") continues to evaluate and monitor the evolving geopolitical conflict in the Middle East and its effect on the Company's first quarter 2026 financial results. Core Lab is working with clients and its local teams to manage operations and mitigate impacts on project execution through a rapidly changing operating environment. The safety and security of the Company's employees remain its highest priority.
Core Laboratories (NYSE:CLB) Shares Cross Above Two Hundred Day Moving Average – Time to Sell?
Core Laboratories Inc. (NYSE: CLB - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $15.60 and traded as high as $16.29. Core Laboratories shares last traded at $15.8820, with a volume of 330,035 shares trading hands. Wall Street Analysts Forecast
DTI or CLB: Which Is the Better Value Stock Right Now?
Investors interested in Oil and Gas - Field Services stocks are likely familiar with Drilling Tools International Corp. (DTI) and Core Laboratories (CLB). But which of these two stocks presents investors with the better value opportunity right now?
Why Is Core Laboratories (CLB) Down 14.2% Since Last Earnings Report?
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?
Core Labs Jumps 79% in 6 Months: Time to Buy or Stay on the Sidelines?
CLB shows strong international demand, free cash flow generation and a solid financial position, but near-term U.S. land activity challenges and margin pressure could limit growth.
Core Laboratories Q4 Earnings Call Highlights
Core Laboratories (NYSE: CLB) reported fourth-quarter and full-year 2025 results that reflected modest top-line growth, continued shareholder returns, and a mix of strength in international demand alongside weakness in U.S. land activity. Management emphasized that demand for the company's proprietary technologies helped offset a seasonally soft U.S. land market, while geopolitical tensions, evolving sanctions, and commodity
Core Laboratories Q4 Earnings Beat Estimates, Expenses Increase Y/Y
CLB expects revenues to range from $124 million to $130 million and earnings per share to be between 11 cents and 15 cents for the first quarter of 2026.
Core Laboratories Inc. (CLB) Q4 2025 Earnings Call Transcript
Core Laboratories Inc. (CLB) Q4 2025 Earnings Call Transcript
Core Laboratories (CLB) Beats Q4 Earnings and Revenue Estimates
Core Laboratories (CLB) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.22 per share a year ago.
Price Targets
Core Laboratories price target lowered to $17 from $18 at Piper Sandler
$17.00
(was $21.78)
Luke Lemoine
·
Piper Sandler
Citigroup Maintains Neutral on Core Laboratories, Raises Price Target to $26
$26.00
(was $26.20)
Citigroup
Morgan Stanley Maintains Equal-Weight on Core Laboratories, Lowers Price Target to $32
$32.00
(was $26.65)
Morgan Stanley